Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid ArthritisChikashi Terao, Noriyuki Yamakawa, Koichiro Yano, et al.
Biological & Pharmaceutical Bulletin|August 2, 2023
Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid ArthritisSho Masui, Atsushi Yonezawa, Miyuki Nakamura, et al.
The Journal of Experimental Medicine|December 1, 2022
Construction of a T cell receptor signaling range for spontaneous development of autoimmune diseaseAtsushi Tanaka, Shinji Maeda, Takashi Nomura, et al.
RMD Open|August 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Yuki Etani, Yuichi Maeda, et al.
Rheumatology (Oxford, England)|May 9, 2024
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort studyRyu Watanabe, Kosuke Ebina, Takaho Gon, et al.
Arthritis Research & Therapy|February 7, 2026
Effects of a personalized exercise program on physical function in older patients with rheumatoid arthritis at high risk of sarcopenia: results of a randomized controlled trialMie Torii, Akira Onishi, Ryuji Uozumi, et al.
Modern Rheumatology|March 19, 2025
Distinct impact of RF and ACPA titer on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
Frontiers in Immunology|February 16, 2026
Hepatocyte growth factor as a driver of synovial inflammation and therapeutic resistance in rheumatoid arthritisQuang Minh Dang, Ryu Watanabe, Takeshi Iwasaki, et al.
International Journal of Rheumatic Diseases|March 5, 2024
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort studyIku Shirasugi, Akira Onishi, Keisuke Nishimura, et al.
Internal Medicine (Tokyo, Japan)|May 1, 2024
A Preliminary Survey of Rheumatologists on the Management of Late-onset Rheumatoid Arthritis in JapanSatoshi Takanashi, Yuko Kaneko, Yutaka Kawahito, et al.
Pageof 23